NSC 366140: Clinical Trials

1 trial of NSC 366140, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow NSC 366140: new trials by email Literature Review of NSC 366140 trials Research Report on NSC 366140

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
Isoniazid with HUEXC030 and RZE, HRZE - Pulmonary Tuberculosis
Phase 2 / Phase 3CompletedOrient Pharma Co., Ltd.5572012-12-062022-06-15

Conditions studied

Tuberculosis, Pulmonary (1)

Sponsors

Orient Pharma Co., Ltd. (1)

Countries

Taiwan (1)

Top investigators

Yu-Pu Hu, PhD (1)